🟢 Citius Pharmaceuticals is trading 6% up in pre-market; no clear catalyst identified

Citius Pharmaceuticals is trading 5.94% up at $0.42 in pre-market on October 22, 2026, with no clear catalyst identified.

• No fresh company-specific announcement explaining the move surfaced in the search.
• The latest company release found was an October 12 investor-conference announcement.
• The supplied market context is broadly negative and does not explain the gain; the reason remains uncertain.